Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bruker (BRKR) EBT Margin (2016 - 2026)

Bruker filings provide 16 years of EBT Margin readings, the most recent being 39.51% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 824.0% to 39.51% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.89%, a 369.0% decrease, with the full-year FY2025 number at 9.89%, down 369.0% from a year prior.
  • EBT Margin hit 39.51% in Q4 2025 for Bruker, up from 8.34% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 39.51% in Q4 2025 to a low of 43.22% in Q4 2022.
  • Median EBT Margin over the past 5 years was 12.92% (2022), compared with a mean of 8.28%.
  • Biggest five-year swings in EBT Margin: tumbled -1826bps in 2021 and later skyrocketed 7142bps in 2023.
  • Bruker's EBT Margin stood at 42.36% in 2021, then decreased by -2bps to 43.22% in 2022, then skyrocketed by 165bps to 28.19% in 2023, then grew by 11bps to 31.27% in 2024, then rose by 26bps to 39.51% in 2025.
  • The last three reported values for EBT Margin were 39.51% (Q4 2025), 8.34% (Q3 2025), and 0.06% (Q2 2025) per Business Quant data.